key: cord-0758510-111ymbdy
authors: Erika, Poggiali; Domenica, Zaino; Paolo, Immovilli; Luca, Rovero; Giulia, Losi; Alessandro, Dacrema; Marzia, Nuccetelli; Giovanni Battista, Vadacca; Donata, Guidetti; Andrea, Vercelli; Andrea, Magnacavallo; Sergio, Bernardini; Chiara, Terracciano
title: Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients
date: 2020-06-09
journal: Clin Chim Acta
DOI: 10.1016/j.cca.2020.06.012
sha: 42de8988c1e9ddb5f21688ff219c9c26a9710a03
doc_id: 758510
cord_uid: 111ymbdy

OBJECTIVE: The dramatic worldwide CoVID-19 infection requires the identification of a reliable and inexpensive tool to quickly discriminate patients with a more unfavorable outcome. METHODS: We performed routine laboratory tests suitable to identify tissue damage and inflammatory status in 123 consecutive CoVID-19 patients admitted to the Emergency Department of the hospital of Piacenza (Emilia-Romagna, Northern Italy). The results were correlated with patients’ respiratory function evaluated by the partial pressure of arterial oxygen to fraction of inspired oxygen ratio (PaO2/FiO2). Results: The most common laboratory abnormalities were lymphocytopenia and elevated values of C-reactive protein (CRP) and lactate dehydrogenase (LDH). Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatine kinase (CK) were also increased. The respiratory performance (PaO2/FiO2) showed a strong inverse correlation with LDH (r= 0.62, r(2) 0.38, p value< 0.0001) and CRP (r= 0.55, r(2) 0.31, p value< 0.0001). PaO2/FiO2 values also showed a significant inverse correlation with age (r= -0.37, p< 0.0001), AST (r= -0.31, p<0.01), WBC (r= -0.49, p<0.0001), neutrophils count (r= -0.5, p<0.001). ROC curves showed a sensitivity of 75% and specificity of 70% for the LDH cut-off value of 450 U/L and a sensitivity of 72% and specificity of 71% for the CRP cut-off value of 11 mg/dl in identifying CoVID-19 with moderate-severe ARDS. CONCLUSIONS: LDH and CRP may be related to respiratory function (PaO2/FiO2) and be a predictor of respiratory failure in CoVID-19 patients. LDH and CRP should be considered a useful test for the early identification of patients who require closer respiratory monitoring and more aggressive supportive therapies to avoid poor prognosis.

0.37, p< 0.0001), AST (r= -0.31, p<0.01), WBC (r= -0.49, p<0.0001), neutrophils count (r= -0.5, p<0.001). ROC 35 curves showed a sensitivity of 75% and specificity of 70% for the LDH cut-off value of 450 U/L and a 36 sensitivity of 72% and specificity of 71% for the CRP cut-off value of 11 mg/dl in identifying CoVID-19 with 37 moderate-severe ARDS. and viral evasion of cellular immune responses play a central role in disease progression and severity [7] . and kidney function and coagulation measures were significantly elevated in patients with both severe and severe disease [9] .

In the present study, we tested the hypothesis that some routine laboratory markers, used to detect tissue 

Clinical features of patients infected with

Abdominal Pain: A Real Challenge in 189

Novel COVID-19 Infection

Can Lung US Help Critical Care Clinicians in the Early Diagnosis 192 of Novel Coronavirus (COVID-19) Pneumonia?

COVID-19: progression of disease and intravascular coagulation -present 195 status and future perspectives

2020;/j/cclm.ahead-of-print

Pathogenic human coronavirus infections: causes and consequences of 202 cytokine storm and immunopathology

Laboratory abnormalities in patients with COVID-2019 infection

Hematologic, biochemical and immune 208 biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 209 (COVID-19): a meta-analysis

World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance: Laboratory 212 testing for 2019-nCoV in humans

Berlin Definition

Management of COVID-19 Respiratory Distress

Challenges in Routine Clinical Chemistry Analysis: Proteins and Enzymes. Editor(s): A. 219

Accurate Results in the Clinical Laboratory

Serum lactate dehydrogenase in interstitial lung disease

The Role of Cytokines including Interleukin-6 in 226 COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

Cytokine release syndrome in severe COVID-19: interleukin-6 229 receptor antagonist tocilizumab may be the key to reduce mortality

C-reactive protein correlates with CT findings